Naphthazarin derivatives (VII): antitumor action against ICR mice bearing ascitic S-180 cells.
Various analogues of 5,8-dimethoxy-1,4-naphthoquinone (DMNQ) such as 2- or 6-(1-hydroxyiminoalkyl)-DMNQs were prepared and evaluated for the antitumor action. (1-Hydroxyiminoalkyl)-DMNQ derivatives expressed greater antitumor action than (1-hydroxyalkyl)- or acyl-DMNQ derivatives. Moreover, 6-(1-hydroxyiminoalkyl)-DMNQ derivatives expressed higher antitumor action than 2-sudstituted ones, suggestive of a steric effect. Some of 6-(1-propyloxyalkyl)-DMNQ derivatives with an alkyl group of butyl to octyl moiety showed T/C values of >400%
College of Pharmacy, Chungnam National University, Taejon, Korea.
G Y
GY
Song
Y
Y
Kim
Y J
YJ
You
H
H
Cho
B Z
BZ
Ahn
D000818:Animals; D000970:Antineoplastic Agents / Q000737:chemistry / Q000627:therapeutic use*; D004354:Drug Screening Assays, Antitumor; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D009285:Naphthoquinones / Q000737:chemistry / Q000627:therapeutic use*; D012510:Sarcoma 180 / Q000188:drug therapy*; D014407:Tumor Cells, Cultured
C409448:2-acyl-5,8-dimethoxy-1,4-naphthoquinone; C409447:6-acyl-5,8-dimethoxy-1,4-naphthoquinone; D000970:Antineoplastic Agents; D009285:Naphthoquinones; C005503:naphthazarin; C063002:2,3-dimethoxy-1,4-naphthoquinone